Schizoaffective disorder is a chronic mental health condition characterized by symptoms of both schizophrenia and mood ...

Classic psychedelics such as psilocybin and LSD enter the brain via the same receptors as serotonin, the body’s “feel good” ...

The Boston-based startup is developing what executives hope will be more effective treatments for depression, anxiety, and ...

Prescription digital therapeutics for mental health have the potential to increase patient access to care, but major barriers ...

MAC Clinical Research – one of Europe's largest independent clinical development firms - has been selected by ...

SINGAPORE: A teenager who received 16 years' jail for killing his schoolmate with an axe at River Valley High School lost his ...

FREMONT, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ophthalmology, CNS (central ...

The Company is currently developing CYB003, a proprietary deuterated psilocin program, about to enter Phase 3 studies for the adjunctive treatment of major depressive disorder and CYB004 ... as “may”, ...

Medicare annual enrollment is underway through Dec. 7, and millions of seniors may find picking a plan is much harder this year than in the past, experts said. But to pay for the changes ...

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel ...

Recent polling found that Trump's plan to ax taxes on Social Security income was appealing to voters. An ABC News/Ipsos poll conducted between October 4 and 8 among 2,631 adults found that Trump's ...